Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith A Morgan

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
JCI Insight|February 20, 2024
Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancerQiang Zhang, Long Jiang, Weiwei Wang, et al.
Neuro-Oncology|April 10, 2025
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Cancer & Metabolism|April 9, 2024
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline gliomaErik R Peterson, Peter Sajjakulnukit, Andrew J Scott, et al.
Research Square|October 4, 2023
Adaptive rewiring of purine metabolism promotes treatment resistance in H3K27M-mutant diffuse midline gliomaErik R Peterson, Peter Sajjakulnukit, Andrew J Scott, et al.
Cancer Discovery|September 27, 2019
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11Xueting Lang, Michael D Green, Weimin Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2021
Screening and Validation of Molecular Targeted RadiosensitizersHenning Willers, Xiao Pan, Nathalie Borgeaud, et al.
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
The Journal of Clinical Investigation|December 25, 2019
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STINGXiaobo Luo, Christopher R Donnelly, Wang Gong, et al.
Molecular Cancer Therapeutics|December 17, 2024
Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic CancerVictoria M Valvo, Qiang Zhang, Long Jiang, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
JCI Insight|February 20, 2024
Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancerQiang Zhang, Long Jiang, Weiwei Wang, et al.
Neuro-Oncology|April 10, 2025
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Cancer & Metabolism|April 9, 2024
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline gliomaErik R Peterson, Peter Sajjakulnukit, Andrew J Scott, et al.
Research Square|October 4, 2023
Adaptive rewiring of purine metabolism promotes treatment resistance in H3K27M-mutant diffuse midline gliomaErik R Peterson, Peter Sajjakulnukit, Andrew J Scott, et al.
Cancer Discovery|September 27, 2019
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11Xueting Lang, Michael D Green, Weimin Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2021
Screening and Validation of Molecular Targeted RadiosensitizersHenning Willers, Xiao Pan, Nathalie Borgeaud, et al.
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
The Journal of Clinical Investigation|December 25, 2019
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STINGXiaobo Luo, Christopher R Donnelly, Wang Gong, et al.
Molecular Cancer Therapeutics|December 17, 2024
Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic CancerVictoria M Valvo, Qiang Zhang, Long Jiang, et al.
Pageof 8